Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation / Robert W. Baker en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348 Título : Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation Tipo de documento: texto impreso Autores: Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor Fecha de publicación: 2023 Artículo en la página: pp. 342-348 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008 [artículo] Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation [texto impreso] / Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor . - 2023 . - pp. 342-348. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348 Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008

Exploratory randomized clinical study of pagoclone in persistent developmental stuttering / Gerald Maguire en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 48-56 Título : Exploratory randomized clinical study of pagoclone in persistent developmental stuttering : The examining pagoclone for persistent developmental stuttering study Tipo de documento: texto impreso Autores: Gerald Maguire, Autor ; David Franklin, Autor ; Nick G. Vatakis, Autor Fecha de publicación: 2022 Artículo en la página: pp. 48-56 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Pagoclone, Tartamudeo, Porcentaje de sílabas tartamudeadas, Ensayo clínico Resumen: Stuttering is a speech disorder in which the flow of speech is disrupted by repetitions, prolongation, and blocks of sounds, syllables, or words. No pharmacological treatments are approved for use in stuttering, and the most common form of treatment is speech therapy. Link: ./index.php?lvl=notice_display&id=29471 [artículo] Exploratory randomized clinical study of pagoclone in persistent developmental stuttering : The examining pagoclone for persistent developmental stuttering study [texto impreso] / Gerald Maguire, Autor ; David Franklin, Autor ; Nick G. Vatakis, Autor . - 2022 . - pp. 48-56. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 48-56 Palabras clave: Pagoclone, Tartamudeo, Porcentaje de sílabas tartamudeadas, Ensayo clínico Resumen: Stuttering is a speech disorder in which the flow of speech is disrupted by repetitions, prolongation, and blocks of sounds, syllables, or words. No pharmacological treatments are approved for use in stuttering, and the most common form of treatment is speech therapy. Link: ./index.php?lvl=notice_display&id=29471

---

1 (1 - 2 / 2)